HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SSII
SS Innovations International, Inc.
There isn't enough reported data to score SSII yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SSII Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SSII's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SSII PE Valuation
SSII has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SSII Forward outlook
There aren't enough analyst estimates for SSII to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SSII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.06 | $0.00 |
| Q1 2026 | -$0.05 | +$0.03 |
| Q4 2025 | -$0.06 | +$0.05 |
| Q3 2025 | -$0.06 | +$0.11 |
| Q2 2025 | -$0.06 | +$0.10 |
| Q1 2025 | -$0.08 | +$0.10 |
| Q4 2024 | -$0.11 | +$0.33 |
| Q3 2024 | -$0.17 | +$0.50 |
SSII has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SSII on profitability, with a higher operating margin.
SSII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.9M | +39% |
| Q1 2026 | $11.1M | +117% |
| Q4 2025 | $14.5M | +79% |
| Q3 2025 | $12.8M | +192% |
| Q2 2025 | $10M | +122% |
| Q1 2025 | $5.1M | +41% |
| Q3 2024 | $4.4M | +101% |
| Q2 2024 | $4.5M | +138% |
SSII has the edge over HIMS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -17 points |
| Q1 2026 | -33% | +83 points |
| Q4 2025 | -5.1% | +18 points |
| Q3 2025 | -14% | +59 points |
| Q2 2025 | 1% | +92 points |
| Q1 2025 | -116% | +155 points |
| Q4 2024 | -23% | N/A |
| Q3 2024 | -73% | +12 points |
SSII's operating margin was −16% last quarter, down 17 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SSII on cash generation, producing positive trailing cash flow while its opponent burns cash.
SSII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.2M | -$465.5K |
| Q1 2026 | -$2.4M | +$4.6M |
| Q4 2025 | -$3.2M | +$152.8K |
| Q3 2025 | -$8.2M | -$7.4M |
| Q2 2025 | -$3.8M | -$634.5K |
| Q1 2025 | -$7M | -$4.2M |
| Q4 2024 | -$3.4M | +$2.4M |
| Q3 2024 | -$844K | +$4.3M |
SSII has burned cash in almost every quarter: −$18M over the past year, against −$15M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SSII on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SSII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +4.1M shares |
| 1 year | +3.2% | +6.6M shares |
| 3 years | +46% | +65.7M shares |
| 5 years | +9379% | +207M shares |
SSII has 209M diluted shares, up 3.2% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SSII Net Leverage
SSII's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SSII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.7 | Oversold |
| Stochastic | 9.7 | Oversold |
SSII's weekly RSI is 22 (oversold) and its Stochastic is 10 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SSII PE vs Healthcare Sector
SSII has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
SSII has stronger trend alignment. HIMS is above 0 of 5 weekly averages versus SSII above 0 of 4.
SSII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.35 | 44% below |
| 20 week MA | $3.11 | 58% below |
| 50 week MA | $4.01 | 67% below |
| 100 week MA | $5.87 | 78% below |
SSII is in a downtrend: it's below all four of its weekly moving averages, and 78% below its 100-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over SSII on returns for 2026, with the stronger performance.
SSII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $3.75 | $8.00 | +113% |
| 2025 | $8.00 | $5.74 | -28% |
| 2026 YTD | $5.74 | $1.32 | -77% |
SSII has finished lower in one of the last two years. It's down 77% so far in 2026.